Last deal

$117.25M
Local Amount - EUR 130M

Amount

Series C

Stage

06.01.2023

Date

3

all rounds

$289.9M

Total amount

date founded

Financing round

General

About Company
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Amolyt, Alizé, Alizé Pharma 3

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Amolyt Pharma develops peptides for rare metabolic and endocrine disorders.
Legal Names

Legal name

Alizé Pharma
Similar Companies
1000
Petra Pharma

Petra Pharma

Petra Pharma is a clinical-stage pharmaceutical company developing novel therapies for cancer and metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

New York, NY, USA

total rounds

2

total raised

$75.55M
Funxional Therapeutics

Funxional Therapeutics

Funxional Therapeutics is a pharmaceutical company that develops products to treat various diseases and disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, UK

total rounds

2

total raised

$12.2M
Immune Pharmaceuticals

Immune Pharmaceuticals

Immune Pharmaceuticals develops personalized antibody therapeutics for inflammatory diseases and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

New York, NY, USA

total rounds

5

total raised

$62.2M
Iltoo Pharma

Iltoo Pharma

ILTOO Pharma is developing biotherapies to balance the immune system and treat autoimmune and inflammatory disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Paris, France
M&A Details
2

Transaction name

Acquired by

AstraZeneca

announced date

14.03.2024

price

$1.05B

Financials

Funding Rounds
9
3

Number of Funding Rounds

$289.9M

Money Raised

Their latest funding was raised on 06.01.2023. Their latest investor ATEM Capital. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
06.01.2023
12
$117.25M
Local Amount - EUR 130M
01.08.2020
Intermediate Capital Group

Intermediate Capital Group

ICG is a global specialist asset manager in private debt, credit, and equity.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Asset Management, Finance

Location

London, UK

count Of Investments

29

count Of Exists

7
Sofinnova Partners

Sofinnova Partners

Sofinnova Partners is a venture capital firm that invests in life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Paris, France

total rounds

1

count Of Investments

287

count Of Exists

40
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

169

count Of Exists

39
Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Asset Management

Location

Dorval, QC, Canada

count Of Investments

49

count Of Exists

6
Co-Investors
Investors
22
6

Number of lead investors

22

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B, Series C
No
Series A
ATEM Capital

ATEM Capital

ATEM Capital Fund LP invests in breakthrough technologies in Life Sciences.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Financial Services, Biotechnology, Venture Capital

Location

New York, NY, USA

count Of Investments

8

count Of Exists

1

Elena Maley

Life Sciences Partners

Life Sciences Partners

LSP is a leading European investment firm that finances private and public life-science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Financial Services, Finance

Location

Amsterdam, Netherlands

count Of Investments

142

count Of Exists

29
OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

561

count Of Exists

82

People

Founders
1
Thierry Abribat
Thierry Abribat

Thierry Abribat

A doctor in Veterinary Medicine and a PhD from the National Polytechnic Institute of Toulouse, Thierry began his career as scientist at Sanofi-Recherche (Toulouse, France), then at University of Montreal and as a consultant to the biopharmaceutical industry. He has then held several executive positions with increasing responsibilities in drug development, business development and management at Theratechnologies (TH.TO, Montreal, Canada) and at OPi SA (Lyon, France), until OPi’s acquisition by EUSA Pharma Inc. He is Manager (gérant) at TAB Consulting, the coordinating holding company and President of the Alizé Pharma companies.

current job

Amolyt Pharma
Amolyt Pharma

organization founded

1

Thierry Abribat

Employee Profiles
3
Mark Sumeray

Mark Sumeray

Chief Medical Officer

Michel Julien

Biopharmaceutical Development Manager

Thierry Abribat

Thierry Abribat

Founder & CEO

Activity

Recent News
9
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month